Intra-articular application of mesenchymal stem cells

Intra-articular application of mesenchymal stem cells is a regenerative medicine procedure in which mesenchymal stem cells, also called mesenchymal stromal cells or MSCs, are applied directly into a joint. The goal is to support a more favorable biological environment inside the joint and help selected patients manage symptoms related to degenerative joint conditions, especially osteoarthritis and joint degeneration. The procedure is most often discussed in relation to the knee and hip, but in selected cases it may also be considered for other joints after specialist evaluation.

Patients usually start researching this treatment when joint symptoms continue despite conservative care. For example, people with persistent knee pain, knee stiffness, hip pain, hip stiffness, or selected patterns of shoulder pain may want to understand whether regenerative medicine is relevant for their condition. These symptoms can affect walking, stairs, sports, getting up from a chair, sleep, work, or basic daily movement. The decision to consider intra-articular MSC treatment is not based on symptoms alone. It depends on the joint involved, imaging findings, stage of degeneration, previous treatment, general health, and realistic treatment goals.

Through ZagrebMed, patients can send an inquiry for case review with the appropriate clinical team. Dr. Trpimir Vrdoljak and Patela Polyclinic may be relevant for orthopedic assessment, treatment planning, and patient guidance when this type of regenerative medicine pathway is being considered.

Key facts

• Treatment type: regenerative medicine injection into the joint space
• Common clinical context: selected degenerative joint conditions, especially knee or hip osteoarthritis
• Typical setting: outpatient procedure, depending on clinic protocol
• Specialist assessment: orthopedic evaluation is usually needed before treatment
• Imaging: X-ray, MRI, ultrasound, or previous reports may be reviewed before deciding suitability
• Recovery: return to activity is usually gradual and depends on the treated joint and medical advice
• Expected results: symptom response varies and cannot be guaranteed
• Limitations: suitability depends on disease stage, joint structure, patient factors, and realistic goals

When patients usually consider intra-articular MSC treatment

This service is usually considered after a patient has already tried simpler measures such as activity modification, physical therapy, exercise planning, weight management, oral or topical medication, or other conservative treatments. In knee osteoarthritis, patients often describe pain during walking, discomfort on stairs, swelling after activity, reduced confidence when loading the joint, or stiffness after rest. In hip osteoarthritis, symptoms often include groin pain, reduced stride length, difficulty putting on socks or shoes, or stiffness after sitting. Shoulder-related cases require careful assessment because shoulder pain can come from the joint, tendons, muscles, instability, or referred pain from the neck.

Intra-articular MSC treatment is not intended to replace a proper diagnosis. The first question is always whether the painful joint is truly the main source of symptoms. A patient with hip pain, for example, may have osteoarthritis, tendon-related pain, spine-related referred pain, or a combination of causes. A patient with knee pain may have cartilage degeneration, meniscus pathology, ligament instability, inflammatory disease, overload, or pain referred from another area. This is why the service should be placed inside a structured orthopedic pathway, not treated as a stand-alone injection.

Who may be a candidate

A possible candidate is usually a patient with persistent joint pain, stiffness, or reduced function where imaging and clinical examination support a degenerative joint condition. The procedure may be discussed when symptoms interfere with daily life, but when the joint has not necessarily reached a stage where joint replacement is clearly the only realistic treatment option. It may also be relevant for patients who want to understand regenerative medicine as part of a broader plan that includes rehabilitation, movement control, strength, and load management.

A patient may not be an ideal candidate if joint degeneration is very advanced, if there is severe deformity, major mechanical instability, active infection, uncontrolled inflammatory disease, or another medical condition that makes injection-based treatment unsafe. It may also be unsuitable if symptoms are mainly caused by a non-joint source, such as lumbar spine disease, tendon rupture, or an inflammatory condition requiring a different treatment strategy. Specialist evaluation is necessary because MSC treatment should not delay surgery or other care when those options are more appropriate.

How the treatment pathway usually works

Step 1: Specialist evaluation

The pathway usually begins with an orthopedic consultation. The doctor reviews the patient’s symptoms, medical history, previous injuries, previous injections or surgeries, current medication, and activity goals. Physical examination helps assess joint movement, pain location, stability, muscle control, walking pattern, and functional limitation. This step is important because regenerative treatment should be considered only after the clinical problem is clearly understood.

Step 2: Imaging and treatment planning

Before treatment is considered, the doctor may review X-rays, MRI, ultrasound, or other imaging reports. Imaging helps show the degree of osteoarthritis, joint-space narrowing, cartilage changes, bone changes, tendon involvement, or other structural findings. The treatment plan also considers age, body weight, activity level, sport or work demands, comorbidities, and expectations. If the case is not suitable for intra-articular MSC application, other conservative, injection-based, rehabilitation, or surgical options may be discussed.

Step 3: Preparation before treatment

Preparation depends on clinic protocol and the exact cell-processing pathway. Patients are usually asked to bring imaging, medical documentation, medication lists, allergy information, and details about previous treatment. Medication review is especially important for patients taking blood thinners, immunosuppressive therapy, or regular anti-inflammatory medication. Some protocols may require laboratory testing, temporary medication adjustments, fasting, or specific instructions before the procedure. The patient should also understand the post-treatment activity plan before the day of treatment.

Step 4: Treatment day

On the day of treatment, the clinical team confirms the treatment plan and prepares the injection area under sterile conditions. The exact steps depend on the source and preparation of the MSC product, the treated joint, and the clinic’s medical protocol. The final preparation is applied into the joint space. Local anesthesia may be used, and image guidance may be considered when it improves accuracy. Hip injections, for example, often require more precise guided placement than superficial joints. The procedure is usually outpatient, but the patient should follow the clinic’s instructions after leaving.

Step 5: Recovery instructions and follow-up

After the procedure, patients usually receive instructions about activity, pain control, warning symptoms, and follow-up. Temporary soreness, swelling, or stiffness can occur after an injection. High-impact activity may need to be avoided for a period of time, and return to sport or heavier physical activity should be gradual. Rehabilitation, muscle strengthening, gait control, and load management may influence the overall result. Follow-up is used to monitor symptoms, function, recovery, and whether additional treatment decisions are needed.

Expected results and realistic limitations

The expected result is not immediate cartilage replacement and should not be presented as a guaranteed cure. In selected patients, the goal is usually to reduce pain, improve stiffness, support function, and help the joint tolerate movement better. Some patients may notice gradual improvement over weeks or months, while others may have limited or no meaningful benefit. Response depends on the diagnosis, joint involved, osteoarthritis stage, alignment, body weight, inflammation level, activity habits, rehabilitation, and individual biological response.

For knee and hip osteoarthritis, the most realistic patient-centered outcomes are usually related to pain control, mobility, stiffness, walking tolerance, and daily function. In shoulder-related cases, the expected benefit depends heavily on whether the problem comes from the joint surface, tendons, instability, or another structure. If the joint is already severely damaged, if pain is caused by advanced mechanical failure, or if function is significantly limited by structural deformity, surgical evaluation may be more appropriate than regenerative injection treatment.

Precautions and safety considerations

Intra-articular MSC treatment should be approached with careful medical guidance. Possible risks include temporary pain, swelling, bruising, stiffness, bleeding, inflammatory flare, infection, or lack of clinical improvement. Any injection into a joint carries a small infection risk, which is why sterile technique, patient selection, and post-procedure instructions are important. Patients should contact a doctor if they develop increasing pain, marked swelling, fever, redness, drainage, worsening limitation of movement, or symptoms that do not follow the expected recovery pattern.

This service is most useful when it is part of a structured orthopedic decision process. Through ZagrebMed, patients can send an inquiry with symptoms, imaging, and previous treatment details so the case can be reviewed and directed toward the appropriate consultation or treatment pathway.